Phase 2 trial of blinatumomab in Philadelphia positive/BCR-ABL positive acute lymphoblastic leukemia. NCT Identifier: NCT02000427.
Author(s):
Publication date:
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.